These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 551896)

  • 41. Effects of K+-canrenoate on the development of DOCA-salt hypertension.
    Vargas F; Haro JM; Jodar E; Soler A; Garcia del Rio C
    J Pharm Pharmacol; 1989 May; 41(5):335-8. PubMed ID: 2569521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diuretic effects on cardiac hypertrophy in the stroke prone spontaneously hypertensive rat.
    Contard F; Glukhova M; Marotte F; Narcisse G; Schatz C; Swynghedauw B; Guez D; Samuel JL; Rappaport L
    Cardiovasc Res; 1993 Mar; 27(3):429-34. PubMed ID: 8490943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of chloride for deoxycorticosterone acetate-salt hypertension in the rat.
    Passmore JC; Whitescarver SA; Ott CE; Kotchen TA
    Hypertension; 1985; 7(3 Pt 2):I115-20. PubMed ID: 3997231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Participation of the nucleus locus coeruleus in DOCA-salt hypertensive rats.
    Chida K; Kawamura H; Hatano M
    Brain Res; 1983 Aug; 273(1):53-8. PubMed ID: 6616232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats.
    Rossoni LV; Pinto VD; Vassallo DV
    Braz J Med Biol Res; 2001 Aug; 34(8):1065-77. PubMed ID: 11471047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W; Schömig A; Dietz R; Weber J; Gross F
    Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of sesamin on altered vascular reactivity in aortic rings of deoxycorticosterone acetate-salt-induced hypertensive rat.
    Matsumura Y; Kita S; Ohgushi R; Okui T
    Biol Pharm Bull; 2000 Sep; 23(9):1041-5. PubMed ID: 10993201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase.
    Marcil J; de Champlain J; Anand-Srivastava MB
    Cardiovasc Res; 1998 Aug; 39(2):492-505. PubMed ID: 9798534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
    Sato Y; Fujita T
    Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion.
    Passmore JC; Jimenez AE; Pierce WM
    Clin Exp Hypertens A; 1991; 13(1):83-102. PubMed ID: 2022074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diuretic indapamide increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium.
    Lalande A; Roux C; Graulet AM; Schiavi P; De Vernejoul MC
    J Bone Miner Res; 1998 Sep; 13(9):1444-50. PubMed ID: 9738517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
    Balasubramaniam G; Lee HS; Mah SC
    Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.